Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108,285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer.
Zhu J, Jiao D, Yan M, Chen X, Wang C, Lu Z, Li L, Sun X, Qin L, Guo X, Zhang C, Qiao J, Li J, Fan Z, Wang H, Zhang J, Yin Y, Fu P, Geng C, Jin F, Jiang Z, Cui S, Liu Z. Zhu J, et al. Among authors: wang h, wang c. Front Oncol. 2021 Apr 29;11:675070. doi: 10.3389/fonc.2021.675070. eCollection 2021. Front Oncol. 2021. PMID: 33996607 Free PMC article.
Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial.
Liu Z, Wang C, Chen X, Zhu J, Sun X, Xia Q, Lu Z, Qiao J, Zhou Y, Wang H, Wang Y, Yan M. Liu Z, et al. Among authors: wang h, wang y, wang c. Eur J Cancer. 2022 Apr;165:157-168. doi: 10.1016/j.ejca.2022.01.022. Epub 2022 Feb 27. Eur J Cancer. 2022. PMID: 35235873 Free article. Clinical Trial.
108,285 results
You have reached the last available page of results. Please see the User Guide for more information.